Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis.
Expert review of anti-infective therapy（2023）
摘要
NMV-rcan reduce all-cause hospitalization and mortality among patients with LC who have COVID-19.
更多查看译文
关键词
COVID-19, liver cirrhosis, nirmatrelvir, ritonavir, SARS-CoV-2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要